Skip to main content

Table 2 Predictors of mortality among a sample of HIV infected cohorts on anti-retroviral treatment in eastern Ethiopia

From: Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study

Independent variables

Unadjusted HR (95% CI)

P-value

¥Adjusted HR (95% CI)

P-value

Age

1.02 (0.99–1.04)

0.131

1.02 (0.99–1.05)

0.156

Sex

    

 Male

1.00

 

1.00

 

 Female

1.05 (0.68–1.64)

0.819

1.16 (0.68–2.00)

0.584

Religion

    

 Muslim

1.00

 

1.00

 

 Christian

0.85 (0.51–1.42)

0.539

0.98 (0.55–1.75)

0.939

Employment

    

 Employed

1.00

 

1.00

 

 Not employed

1.05 (0.66–1.67)

0.827

0.94 (0.58–1.52)

0.788

Marital status

    

 Not married

1.00

 

1.00

 

 Married

0.92 (0.60–1.41)

0.694

0.97 (0.60–1.56)

0.884

Education

    

 No education

1.00

 

1.00

 

 Primary

1.58 (0.79–3.16)

0.193

2.79 (1.26–6.16)

0.011

 Secondary or above

1.42 (0.70–2.87)

0.331

1.40 (0.61–3.22)

0.435

Baseline functional status

    

 Working

1.00

 

1.00

 

 Ambulatory

1.28 (0.77–2.13)

0.337

1.14 (0.64–2.04)

0.651

 Bedridden

5.33 (3.05–9.30)

0.000

4.09 (2.12–7.90)

0.000

10% weight loss

    

 No

1.00

 

1.00

 

 Yes

4.41 (1.08–17.92)

0.038

4.93 (1.20–20.41)

0.027

CD4 category

    

 ≤ 200

1.00

 

1.00

 

 201–300

0.42 (0.19–0.92)

0.029

0.40 (0.17–0.93)

0.034

 >300

0.67 (0.24–1.82)

0.428

0.86 (0.30–2.41)

0.77

WHO category

    

 Stage I and II

1.00

 

1.00

 

 Stage III

1.35 (0.77–2.36)

0.294

1.60 (0.85–3.04)

0.15

 Stage IV

3.35 (1.80–6.24)

0.000

3.19 (1.51–6.76)

0.002

  1. ¥Global test of proportionality of hazards derived from Schoenfeld residuals not significant (df = 13, ch2 = 13, p = 0.108).